We are here to help you overcome challenges.
Our goal is to bring innovative controlled release encapsulation systems across personal care and pharmaceutical applications. We aim to make people’s lives better, to change the world one product innovation at a time.
Strategy
Salvona Technologies LLC is focused on manufacturing proprietary advanced encapsulation systems that modify the way functional and active ingredients are being delivered. These systems are used to formulate innovative and highly functional products with unique features, including long-lasting release, triggered release, and targeted delivery. The encapsulation technologies are designed to address production and application issues, such as stability of raw materials, formulation practicality, environmental and safety concerns, and user compliance.
Salvona has established an umbrella of intellectual property covering its broad technology platforms that provides the company with the freedom to operate and apply these technologies in various markets including consumer health care, dermatology, pharmaceuticals, cosmetics, oral hygiene, and general consumer care. Salvona’s patent portfolio covers both the compositions and applications of its technology platforms. Since its founding, the company has applied for nearly 100 patents.
Salvona is privately owned and operates in partnership with ZSCHIMMER & SCHWARZ CHEMIE GmbH.
Technology
Salvona’s proprietary technology platforms include nano-spheres, sub-micron spheres, microspheres, invisible soluble patches, and biodegradable devices. Currently, Salvona’s technologies are being used in various skin care products, i.e., underarm antiperspirant applicators, dermatological anti-acne products, skin exfoliators, body & skin treatments for anti-aging and atopic dermatitis, anti-dandruff scalp products, medical biodegradable diagnostic devices such as a camera pill, professional hair care products, and wellness (spa) products as well as food supplements and air care products.
Facilities
Salvona’s headquarters is located in Dayton, Central New Jersey, approximately 50 minutes south of New York City and 75 minutes north of Philadelphia. Conveniently located just off exit 8A on the New Jersey Turnpike, the company occupies a headquarters suite with an office complex, state of the art product development facility, QA/QC analytical laboratory, pilot production plant, and GMP production facility for sub-micron and microspheres. Large-scale production, all of which is done under cGMP FDA regulations, is currently outsourced to approved contract manufacturers.
How we got here...
1998
Salvona is founded by Drs. Sam & Adi Shefer using years of experience in the field and research at MIT.
2002
Salvona moves to new operation facility located in Dayton, NJ.
2004
Patent portfolio continues to grow with over 50 issued patents and applications.
2007
Customer base continues to expand, reaching more Fortune 500 companies and new entrepreneurs than ever.
2012
Salvona begins partnership with ZSCHIMMER & SCHWARZ CHEMIE GmbH.
2013
Salvona begins construction on new GMP facility in central NJ to be completed by 2014.